High Content Screening Identifies Synthetic Lethality Of Retinoid Receptor Agonists In IKZF1-Mutated BCR-ABL1 positive Acute Lymphoblastic Leukemia
Michelle L. Churchman(ASTER), Charles G. Mullighan(St. Jude Children's Research Hospital), Shann-Ching Chen(St. Jude Children's Research Hospital), Debbie Payne-Turner(St. Jude Children's Research Hospital), R. Kiplin Guy(St. Jude Children's Research Hospital), Faiyaz Notta(Ontario Institute for Cancer Research), Jonathan Low(St. Jude Children's Research Hospital), Laura J. Janke(St. Jude Children's Research Hospital), John E. Dick(University of Toronto), Taosheng Chen(St. Jude Children's Research Hospital), Jing Ma(St. Jude Children's Research Hospital), Mark J. Althoff(University of Colorado Anschutz Medical Campus)
Cited by 3
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
|Military Medical Research|2020|2.4k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k